| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
WPD Pharmaceuticals Inc (F: 8SV1)
8SV1 Technical Analysis
5
| As on 11th Jul 2022 8SV1 STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.12 & Strong Sell for SHORT-TERM with Stoploss of 0.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
8SV1STOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | -0.01 | -50.00 |
| Low | 0.01 | 1 Week | 0.00 | 0.00 |
| Close | 0.01 | 1 Month | -0.03 | -75.00 |
| Volume | N/A | 1 Year | -0.24 | -96.00 |
| 52 Week High 0.29 | 52 Week Low 0.01 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| 8SV1 Daily Charts |
8SV1 Intraday Charts |
Whats New @ Bazaartrend |
8SV1 Free Analysis |
|
|
8SV1 Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
8SV1 Forecast November 2024
| 4th UP Forecast | 0.14 |
| 3rd UP Forecast | 0.1 |
| 2nd UP Forecast | 0.07 |
| 1st UP Forecast | 0.05 |
| 1st DOWN Forecast | -0.03 |
| 2nd DOWN Forecast | -0.05 |
| 3rd DOWN Forecast | -0.08 |
| 4th DOWN Forecast | -0.12 |
8SV1 Weekly Forecast
| 4th UP Forecast | 0.09 |
| 3rd UP Forecast | 0.06 |
| 2nd UP Forecast | 0.05 |
| 1st UP Forecast | 0.03 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.03 |
| 3rd DOWN Forecast | -0.04 |
| 4th DOWN Forecast | -0.07 |
8SV1 Forecast2024
| 4th UP Forecast | 0.55 |
| 3rd UP Forecast | 0.38 |
| 2nd UP Forecast | 0.27 |
| 1st UP Forecast | 0.16 |
| 1st DOWN Forecast | -0.14 |
| 2nd DOWN Forecast | -0.25 |
| 3rd DOWN Forecast | -0.36 |
| 4th DOWN Forecast | -0.53 |
WPD Pharmaceuticals Inc ( F Germany Symbol : 8SV1 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
8SV1 Business Profile
WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat central nervous system tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company's drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of glioblastoma multiforme that is in the pre-clinical trial; and Annamycin to treat acute myeloid leukemia (AML) and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada. Address: 789 West Pender Street, Vancouver, BC, Canada, V6C 1H2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service